| Product Code: ETC9556254 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Guanylate Cyclase-C Agonists Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Guanylate Cyclase-C Agonists Market - Industry Life Cycle |
3.4 Sweden Guanylate Cyclase-C Agonists Market - Porter's Five Forces |
3.5 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.6 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.8 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Guanylate Cyclase-C Agonists Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal diseases in Sweden |
4.2.2 Growing awareness about the benefits of guanylate cyclase-c agonists in treating gastrointestinal disorders |
4.2.3 Technological advancements in drug delivery systems for guanylate cyclase-c agonists |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Sweden |
4.3.2 High cost associated with guanylate cyclase-c agonist therapies |
4.3.3 Limited availability of guanylate cyclase-c agonist drugs in the Swedish market |
5 Sweden Guanylate Cyclase-C Agonists Market Trends |
6 Sweden Guanylate Cyclase-C Agonists Market, By Types |
6.1 Sweden Guanylate Cyclase-C Agonists Market, By Drug |
6.1.1 Overview and Analysis |
6.1.2 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Drug, 2021- 2031F |
6.1.3 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Trulance, 2021- 2031F |
6.1.4 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Linzess, 2021- 2031F |
6.2 Sweden Guanylate Cyclase-C Agonists Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Irritable Bowel Syndrome, 2021- 2031F |
6.2.3 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Chronic Idiopathic Constipation, 2021- 2031F |
6.2.4 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Guanylate Cyclase-C Agonists Market, By Dosage |
6.3.1 Overview and Analysis |
6.3.2 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Tablet, 2021- 2031F |
6.3.4 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Guanylate Cyclase-C Agonists Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.4 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden Guanylate Cyclase-C Agonists Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Sweden Guanylate Cyclase-C Agonists Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Sweden Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Guanylate Cyclase-C Agonists Market Import-Export Trade Statistics |
7.1 Sweden Guanylate Cyclase-C Agonists Market Export to Major Countries |
7.2 Sweden Guanylate Cyclase-C Agonists Market Imports from Major Countries |
8 Sweden Guanylate Cyclase-C Agonists Market Key Performance Indicators |
8.1 Patient adherence rate to guanylate cyclase-c agonist treatment |
8.2 Number of clinical trials evaluating the efficacy of guanylate cyclase-c agonists |
8.3 Rate of adoption of guanylate cyclase-c agonists by healthcare providers in Sweden |
9 Sweden Guanylate Cyclase-C Agonists Market - Opportunity Assessment |
9.1 Sweden Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.2 Sweden Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.4 Sweden Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Sweden Guanylate Cyclase-C Agonists Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Sweden Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Guanylate Cyclase-C Agonists Market - Competitive Landscape |
10.1 Sweden Guanylate Cyclase-C Agonists Market Revenue Share, By Companies, 2024 |
10.2 Sweden Guanylate Cyclase-C Agonists Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here